According to the FDA briefing document, it looks like the FDA will want more trials...
Here's my question: If the advisory committee recommends it for approval, the FDA could possibly just grant conditional approval of Onrigin, right? That would mean they would have to conduct another trial after "approval", before they could market it.
JMO.
Let me know your thoughts...
All posts are in my opinion. Do not buy or sell based on my opinion.